Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SELECT-2
2008-007649-30Phase 2Terminated
- Sponsor
- Biolex Therapeutics
- Start
- Feb 2009
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of interferon alfa-2b in chronic hepatitis C (CHC) (4 arms), sponsored by Biolex Therapeutics. Primary endpoint: Early virologic response. Started Feb 2009; status: terminated.
02
Drugs
interferon alfa-2b
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on 2008-007649-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007649-30.